DekaBank Deutsche Girozentrale’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,004
Closed -$382K 1391
2022
Q4
$382K Sell
1,004
-13,000
-93% -$4.33M ﹤0.01% 1096
2022
Q3
$3.45M Sell
14,004
-311
-2% -$84K 0.01% 596
2022
Q2
$3.63M Buy
14,315
+44
+0.3% +$11.9K 0.01% 599
2022
Q1
$4.79M Sell
14,271
-3,441
-19% -$1.06M 0.01% 574
2021
Q4
$6.39M Buy
17,712
+4,338
+32% +$1.47M 0.02% 512
2021
Q3
$4.4M Buy
13,374
+6,448
+93% +$2.18M 0.01% 557
2021
Q2
$2.15M Buy
6,926
+329
+5% +$101K 0.01% 705
2021
Q1
$2.04M Buy
6,597
+1,396
+27% +$447K 0.01% 694
2020
Q4
$1.67M Sell
5,201
-1,026
-16% -$284K 0.01% 716
2020
Q3
$1.68M Buy
6,227
+202
+3% +$58.2K 0.01% 628
2020
Q2
$1.44M Buy
6,025
+550
+10% +$110K 0.01% 573
2020
Q1
$803K Buy
5,475
+2,565
+88% +$426K 0.01% 656
2019
Q4
$491K Sell
2,910
-15,515
-84% -$2.88M ﹤0.01% 836
2019
Q3
$3.26M Sell
18,425
-9,238
-33% -$2M 0.02% 425
2019
Q2
$7.11M Buy
27,663
+20,760
+301% +$5.51M 0.04% 362
2019
Q1
$2.9M Sell
6,903
-8,452
-55% -$2.81M 0.02% 529
2018
Q4
$4.9M Buy
15,355
+8,452
+122% +$2.94M 0.03% 360
2018
Q3
$2.9M Buy
6,903
+1,033
+18% +$407K 0.02% 541
2018
Q2
$2.52M Buy
+5,870
New +$2.13M 0.02% 530

Other funds holding ABMD

DekaBank Deutsche Girozentrale's ABMD Position: Q1 2023 in Review

DekaBank Deutsche Girozentrale sold out of Abiomed Inc (ABMD) in Q1 2023, closing a stake of 1,004 shares — an estimated $382K sold.

DekaBank Deutsche Girozentrale first reported a position in ABMD in Q2 2018 and held it in 19 quarters. The position peaked at $7.11M in Q2 2019. 2 funds tracked by Wall St. Rank hold ABMD as of Q1 2023.

  • DekaBank Deutsche Girozentrale reported no remaining Abiomed Inc position as of Q1 2023 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 1,004 Abiomed Inc shares in Q1 2023, an estimated $382K.
  • DekaBank Deutsche Girozentrale first reported a position in Abiomed Inc in Q2 2018 and held it in 19 quarters.
  • DekaBank Deutsche Girozentrale's Abiomed Inc position peaked at $7.11M in Q2 2019.
  • 2 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2023, filed 24 Apr 2023.